Suchergebnisse

Objective: According to a prior study, there are substantial lapses in journal coverage in the Social Work Abstracts (SWA) database. The current study provides a replication and extension. Method: The longitudinal pattern of coverage of thirty-three journals categorized in SWA as core journals (published in the 1989-1996 period) is examined. Results: The proportion of issues missing from SWA is significantly greater than 0, increase over time, and is significantly biased in favor of NASW journals. Conclusion: The errors in SWA reported here, combined with those previously reported, will exert a long-term negative impact on scholarship unless their existence becomes known to all SWA users and they take steps to compensate for the situation.

Objective: The current study seeks to provide estimates of the adequacy of journal coverage in the Social Work Abstracts (SWA) database. Method: A total of 23 journals listed in the Journal Citation Reports social work category during the 1997 to 2005 period were selected for study. Issue-level coverage estimates were obtained for SWA and PsycINFO, the comparison database. Results: Both databases provided less than optimal coverage of social work journals, and SWA performed significantly worse than did PsycINFO. Both databases provided better coverage of National Association of Social Workers (NASW) Press journals than non—NASW Press journals. Conclusion: The results provide evidence of substantial deficits in SWA that merit serious concern.

IntroductionAfter the initial approval of the use of tenofovir disoproxil fumarate‐emtricitabine (TDF/FTC) by the US Food and Drug Administration in 2012 for anti‐HIV pre‐exposure prophylaxis (PrEP), uptake was initially limited, but more recent community surveys and expert opinion suggest wider acceptance in some key populations.DiscussionDemonstration projects are underway to determine the best practices in the United States to identify at‐risk individuals in primary care and sexually transmitted disease clinics who could benefit from PrEP. Studies of PrEP in combination with behavioural interventions are being evaluated. Studies to evaluate the use of PrEP by HIV‐uninfected women in HIV‐discordant couples interested in safe conception are also getting underway. The optimal deployment of PrEP as part of a comprehensive national HIV/AIDS strategy in the United States has been limited by lack of knowledge among some at‐risk people and by some medical providers indicating that they do not feel sufficiently knowledgeable and comfortable in prescribing PrEP. Studies are underway to determine how to assist busy clinicians to determine which of their patients could benefit from PrEP. Although most federal health insurance programmes will cover most of the costs associated with PrEP, underinsured patients in states that have not enacted health reform face additional challenges in paying for PrEP medication and appropriate clinical monitoring.ConclusionsPrEP implementation in the United States is a work in progress, with increasing awareness and uptake among some individuals in key populations.